Back

Atrial fibrillation screening to prevent stroke in patients with high NT-proBNP - a post-hoc analysis of the randomized LOOP study

16 April 2023 (08:30 - 08:40)
Organised by:
Congress Presentation Part of: Atrial Fibrillation - Round 1 - Drugs, Prevention Diagnostic Methods EHRA Premium Access EHRA 2023

About the speaker

Photo
Doctor Soeren Zoega Diederichsen

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

5 More presentations in this session

Presentation thumbnail
Atrial fibrillation is an independent risk factor for heart failure progression and pump failure mortality in HFpEF:: a propensity score matched analysis of the TOPCAT Americas study
Professor D. Shah (Geneva, CH)
Abstract Slides Video
Presentation thumbnail
Effects of antiarrhythmics on atrial high rate episodes and progression to clinical atrial fibrillation (ANTI-AHRE)
Doctor S. Simovic (Kragujevac, RS)
Abstract Slides Video
Presentation thumbnail
Improved prognosis with integrated care management including early rhythm control and healthy lifestyle modification in patients with concurrent atrial fibrillation and diabetes mellitus
Doctor H. Ahn (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation and in-hospital mortality in Covid-19 patients
Doctor I. Kotadia (London, GB)
Abstract Slides Video
Presentation thumbnail
Active monitoring for atrial fibrillation (AMALFI): a streamlined randomised controlled trial of remote screening for subclinical atrial fibrillation
Doctor R. Wijesurendra (Oxford, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial Fibrillation - Round 1 - Drugs, Prevention
Video

The Event

Event poster

EHRA 2023

16 April 2023 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Effects of long-term continuous screening for atrial fibrillation on heart failure events - results from the randomized LOOP Study
thumbnail
Congress Presentation
Atrial fibrillation screening effects according to genetic risk: a secondary analysis of the randomized LOOP study
thumbnail
Congress Presentation
Screening for atrial fibrillation: ready for prime time?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources